Clinical Trial Update: A Clinical Trial of TQB3006 Tablets in Patients With Advanced Malignant Cancer [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 clinical trial evaluating TQB3006 tablets in patients with advanced malignant cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• TQB3006 (TQB3006)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Advanced Malignant Neoplasm | Phase 1 | Status: COMPLETED